What is the Baxter International Inc. stock price forecast?

Baxter International Inc. is currently trading at $20.86. View real-time AI analysis on Alpha Lenz.

What is Baxter International Inc. insider trading activity?

View the latest insider trading data for Baxter International Inc. on Alpha Lenz.

What is Baxter International Inc.'s P/E ratio?

Baxter International Inc.'s P/E ratio is -11.2.

Baxter International Inc.

NYSE · BAX

$20.86+0.37(+1.81%)Pre-market

Ask about Baxter International Inc.'s future dividend policy...

Alpha Chat Insight

“Baxter International Inc. trades at a P/E of -11.2 (undervalued) with modest ROE of -14.6%.”

Ask for details →

Company Overview

Baxter International Inc. is a leading global healthcare company specializing in medical products and services. With a strong focus on advancing patient care, Baxter develops and manufactures a wide range of critical care and renal products. The company's offerings include intravenous (IV) solutions, infusion pumps, and parenteral nutrition therapies, which play vital roles in hospital and clinical settings. Baxter also caters to the needs of chronic kidney disease sufferers, providing dialysis treatments and continuous renal replacement therapies. Operating in diverse geographical areas, Baxter International significantly impacts the healthcare sector, servicing hospitals, healthcare professionals, and patients worldwide. Established in 1931 and headquartered in Deerfield, Illinois, the company is well-regarded for its commitment to innovation and quality in the medical field.

CEOMr. Andrew P. Hider

Websitehttps://www.baxter.com

SectorHealthcare

IndustryMedical Instruments & Supplies

Employees38,000

Company Statistics

FY 2025

Profile

$10.70BMarket Cap

$11.24BRevenue

0.00Shares Out

38,000Employees

Margins

30.05%Gross

11.21%EBITDA

1.57%Operating

-4.49%Pre-Tax

-8.51%Net

Valuation

-11.18P/E

1.75P/B

0.95EV/Sales

14.66EV/EBITDA

33.13P/FCF

Growth (CAGR)

-8.14%Rev 3Yr

-0.75%Rev 5Yr

-33.61%Op Inc 3Yr

-35.59%Op Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-4.18%ROA

-14.62%ROE

-0.94%ROIC

Financial Health

$1.97BCash & Cash Equivalents

$11.99BNet Debt

228.66%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Baxter International Inc. trades at a P/E of -11.2 (undervalued) with modest ROE of -14.6%.”

Ask for details →

Frequently Asked Questions

Baxter International Inc. (ticker: BAX) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 38,000 employees. Market cap is $10.7B.

The current price is $20.86 with a P/E ratio of -11.18x and P/B of 1.75x.

ROE is -14.62% and operating margin is 1.57%. Annual revenue is $11.2B.